Current location:Home > Pharmaceutical

Ketanserin

  • CAS No.:74050-98-9
  • Purity:99%
inquiry

Factory Supply industrial standard Ketanserin 74050-98-9 In Stock

  • Molecular Formula:C22H22FN3O3
  • Molecular Weight:395.433
  • Melting Point:227-235 °C 
  • Refractive Index:1.592 
  • PKA:7.5(at 25℃) 
  • PSA:75.17000 
  • Density:1.281 g/cm3 
  • LogP:2.36170 

Ketanserin(Cas 74050-98-9) Usage

Purification Methods

It has been purified by recrystallisation from 4-methyl-3-pentanone [Peeters et al. Cryst Structure Commun 11 375 1982, Kacprowicz et al. J Chromatogr 272 417 1983, Davies et al. J Chromatogr 275 232 1983]. It is an antihypertensive.

Definition

ChEBI: A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Brand name

SEREFREX

InChI:InChI=1/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)

74050-98-9 Relevant articles

Ketoserin intermediate and preparation method of ketoserin

-

Paragraph 0045-0046; 0059-0061, (2021/01/15)

The invention discloses a preparation me...

Reinvestigation of the synthesis of ketanserin (5) and its hydrochloride salt (5.HCl) via 3-(2-chloroethyl)-2,4-(1H,3H)-quinazolinedione (2) or dihydro-5H-oxazole(2,3-b)quinazolin-5-one (1)

Fakhraian, Hossein,Heydary, Mehdi

, p. 151 - 156 (2014/02/14)

The synthesis of ketanserin (5) and its ...

Floating pharmaceutical composition comprising an active phase and a non-active phase

-

, (2010/04/23)

The invention concerns a floating pharma...

Piperidinylalkyl quinazoline compounds, composition and method of use

-

, (2008/06/13)

Novel quinazoline derivatives, comprisin...

74050-98-9 Process route

(4-fluorophenyl)-piperidin-4-ylmethanone
56346-57-7

(4-fluorophenyl)-piperidin-4-ylmethanone

2,3-dihydro-5H-oxazolo<2,3-b>quinazolin-5-one
52727-44-3

2,3-dihydro-5H-oxazolo<2,3-b>quinazolin-5-one

ketanserine
74050-98-9

ketanserine

Conditions
Conditions Yield
In neat (no solvent); at 110 ℃;
85%
In toluene; for 40h; Reflux;
80%
4-(4-fluorobenzoyl)piperidine hydrochloride
25519-78-2

4-(4-fluorobenzoyl)piperidine hydrochloride

4-methyl-2-pentanone
108-10-1

4-methyl-2-pentanone

3-(2-chloroethyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline
5081-87-8

3-(2-chloroethyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline

ketanserine
74050-98-9

ketanserine

Conditions
Conditions Yield
With sodium carbonate; In water;
2,2 parts (27%)

74050-98-9 Upstream products

  • 25519-78-2
    25519-78-2

    4-(4-fluorobenzoyl)piperidine hydrochloride

  • 108-10-1
    108-10-1

    4-methyl-2-pentanone

  • 5081-87-8
    5081-87-8

    3-(2-chloroethyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline

  • 1207-75-6
    1207-75-6

    2,4-Dioxo-3-(2-hydroxyethyl)-1,2,3,4-tetrahydroquinazoline

74050-98-9 Downstream products

  • 298696-31-8
    298696-31-8

    2-[3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2,4-dioxo-3,4-dihydro-1(2H)-quinazolinyl]-N,N-dimethylacetamide hydrochloride

  • 76330-73-9
    76330-73-9

    Ketanserinol

  • 83846-83-7
    83846-83-7

    ketanserin tartrate

*Product Name
CasNo
Purity
Quantity
Company name
*Email
*Other Description
*Verification code:
Submit
Purchase Posted Successfully, our staff will contact you within 24 hours.